Detalhe da pesquisa
1.
Factors associated with refractoriness or early progression after idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma: U.S. Myeloma Immunotherapy Consortium real world experience.
Haematologica
; 2023 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855036
2.
ATG prevents severe acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 17(8): 1237-44, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21215811
3.
Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids.
Haematologica
; 96(9): 1351-6, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21565902